Drug · DIN 02458136
ALECENSARO
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since October 14, 2016; first marketed October 14, 2016.
- Drug Identification Number (DIN)
- 02458136
- Company (DIN owner)
- Hoffmann-La Roche LimitedMississauga, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Capsule
- Route
- Oral
- Therapeutic class (ATC)
- Alectinib L01ED03
- Class
- Human
- Record last updated
- September 4, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| ALECTINIB (ALECTINIB HYDROCHLORIDE) | 150 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- September 29, 2016: NOC 18535New Drug Submission (NDS)
Recalls and safety alerts that mention it
Health Canada’s recall notices do not carry licence numbers, so these are matched by name: notices whose title or product names “alecensaro”. A notice may cover another product or only some lots: read it to see what it covers.
- ALECENSARO (alectinib) and the Risk of Severe HypertriglyceridemiaApril 22, 2026 · Drugs · New safety information - Product safety - Adverse reaction